Richard J. Hawkins

Operating Partner

Richard J. Hawkins currently serves as the Chief Executive Officer of Lumos Pharma.  Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the growth of that organization to over 700 employees.  Pharmaco offered a full range of clinical drug development services to the pharmaceutical industry, including Phase I-IV clinical trials and analytical chemistry services.  The company merged with Applied Bioscience International.  Mr. Hawkins managed their 2000 employee international Research & Development operations.  Pharmaco merged with PPD of Wilmington, NC to form PPD Pharmaco, one of the largest clinical contract research organizations in the world.

After selling Pharmaco, Mr. Hawkins founded id2, a pharmaceutical and biotechnology research management company.  Through his position as Chairman and Chief Executive Officer at id2, he has served as an advisor and mentor in the start-up of numerous companies, including Sensus Drug Development Corporation. Sensus, a biotechnology company, developed Growth Hormone Antagonists for use in acromegaly, the complications of diabetes and the regulation of growth hormone in the treatment of specific types of tumors.  Mr. Hawkins co-founded Sensus and served as the Chairman, and Sensus was ultimately sold to Pfizer Corporation (NYSE: PFE).

In addition to Sensus, Mr. Hawkins was co-founder and Director of Covance Biotechnology Services, Inc., a full service contract manufacturer of recombinant proteins located in Research Triangle Park, NC. Covance Biotechnology Services was sold to Akzo Nobel (AMS: AKZA) in early 2001.

Mr. Hawkins also co-founded and served as Chief Executive Officer, President and Chairman of LabNow, a diagnostic device company established to improve the quality of patient care and lower overall treatment costs through deployment of rapid, point-of-care, physician office-based diagnostic testing systems.

Mr. Hawkins serves as a Director for SciClone Pharmaceuticals Inc. (SCLN) and Cytori Therapeutics (CYTX).  Mr. Hawkins was inducted into the Hall of Honor for the College of Natural Sciences at the University of Texas.  In 2006, he received Ohio University’s Distinguished Business Achievement Award, and was named one of the top 10 Life Sciences Chief Exceutive Officers in Texas by the Texas Healthcare & Bioscience Institute.

Mr. Hawkins is a member of the National Ernst and Young Entrepreneur of the Year Hall of Fame.  In 2015, he received Ohio University’s Konneker Medal, the highest award given to a faculty member or former student for entrepreneurial excellence.

Mr. Hawkins resides in Austin, Texas and maintains a residence near Columbus, Ohio.